Back to News
Market Impact: 0.2

CelLBxHealth reaffirms revenue guidance

ANPCY
Company FundamentalsCorporate Guidance & OutlookManagement & GovernanceAnalyst Insights
CelLBxHealth reaffirms revenue guidance

CelLBxHealth said it remains on track to deliver 2026 revenue of at least £2.1m, a 50% increase versus 2025, while it searches for a new chief executive. The update is a modest positive outlook but tempered by ongoing leadership transition.

Analysis

CelLBxHealth said it remains on track to deliver 2026 revenue of at least £2.1m, a 50% increase versus 2025, while it searches for a new chief executive. The update is a modest positive outlook but tempered by ongoing leadership transition.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.10

Ticker Sentiment

ANPCY0.35